摘要 : ? 2023 Elsevier B.V.From the 1960s to the early 2000s, alkylating agents (e.g., melphalan, cyclophosphamide, and bendamustine) remained a key component of standard therapy for newly-diagnosed or relapsed/refractory multiple myelom... 展开
作者 | Costa B.A. Mouhieddine T.H. Ortiz R.J. Richter J. |
---|---|
作者单位 | |
期刊名称 | 《Critical reviews in oncology/hematology》 |
总页数 | 7 |
语种/中图分类号 | en / R73 |
关键词 | Alkylators Autologous stem cell transplantation Bendamustine CAR T-cell therapy Cyclophosphamide Lymphodepletion Melphalan Multiple myeloma |
馆藏号 | N2007EPST0000581 |